一株“山茶花”的故事，能否撑起林清轩港股IPO？

Core Insights - Lin Qingxuan, a beauty company, has positioned itself in the high-end skincare market with its flagship product, Camellia Oil, which has a gross margin of 82.5% [1][6] - The company has shown significant revenue growth, with sales increasing from 691 million yuan in 2022 to 1.21 billion yuan in 2024, representing a compound annual growth rate (CAGR) of 32.3% [1][5] - Lin Qingxuan plans to use the funds raised from its Hong Kong IPO to enhance brand value, expand sales channels, and improve production and supply chain capabilities [1] Revenue and Product Performance - The Camellia Oil product line has contributed over 30% of the company's revenue, with sales reaching 218 million yuan in 2022, 284 million yuan in 2023, and 448 million yuan in 2024 [3][5] - The market for facial oils in China is rapidly growing, with a projected increase from 900 million yuan in 2019 to 5.3 billion yuan in 2024, achieving a CAGR of 42.8% [2] - Lin Qingxuan's product strategy includes continuous upgrades to its core products and the introduction of new SKUs, resulting in a diverse product offering of 188 SKUs by the end of 2024 [3][6] Sales Channels and Market Strategy - The company has expanded its sales channels, with nearly 60% of its revenue coming from online sales by 2024, up from 45.2% in 2022 [9][10] - Lin Qingxuan has focused on offline expansion, with over 95% of its 506 stores located in high-end shopping malls, contributing significantly to its revenue [8] - The company has successfully leveraged live-streaming e-commerce, with its founder participating in live broadcasts to boost online sales [10] Investment and Valuation - Lin Qingxuan has attracted notable investors, including YOUNGOR and various venture capital firms, indicating strong market interest [11][12] - The company's valuation before its IPO is estimated to be around 3.84 billion yuan, based on recent equity transactions [12][13] - Compared to other publicly listed beauty companies, Lin Qingxuan's revenue is relatively smaller, with 1.21 billion yuan in 2024, highlighting the challenges it may face in meeting IPO valuation expectations [14]